Learn about Our New Egg Freezing Pricing!

Chelsea Fertility offers patients a fee of $9,900 for 20 eggs frozen or four cycles (whichever occurs first). Learn how egg freezing gives women the opportunity to conceive their own biological child within a wider time frame.

Explore Egg Freezing Today

Schedule a Free Private Consultation Today!

We offer a one-time, free initial consult/second opinion for self-pay patients. We also accept many health insurance plans that cover this appointment. Further details are provided in the free consult/second opinion confirmation email.

Request a Free Consultation


Selected Publications: Dr. Beth Hartog

  • Riozin-Towle L, Meltzer HL, Hall EJ, Bigalow JC and Hartog B: Hypoxia mediated drugs and chemosensitization. Presented at 24th Annual Scientific Meeting of the American Society of Therapeutic Radiologists. Kissimee, Florida, October 25-29, 1982.
  • Astor, MB, Parham JC, Hall EJ, Templeton MA and Hartog B: A 3-nitro triazole as a hypoxic cell sensitizer. British Journal of Cancer. 47: 155-157, 1983.
  • Astor MB, Hall EJ, Bigalow JC and Hartog B: In Vitro studies with two human cell lines deficient in glutathione. Seventh International Congress of Radiation Research. Amsterdam, The Netherlands, July 3-8, 1983.
  • Riozin-Towle L, Hall EJ, Meltzer HL and Hartog B: Chemosensitization In Vitro. Thirty-Second Annual Meeting of the Radiation Research Society, Orlando, Florida, March 25-29, 1984.
  • Astor MB, Hall EJ, and Hartog B: Thiols and radiosensitivity. Abstracts of Thirty-Second Annual Meeting of the Radiation Research Society. Orlando, Florida, March 25-29, 1984.
  • Cruz J, Dubey A, Hartog B and Gindoff P: Is blastocyst transfer useful as an alternative treatment for IVF patients with previous IVF failure? Abstract P-355, Proceedings of the Annual Meeting of the American Society of Reproductive Medicine, October 1998.
  • Stratton P, Hartog B, Hajizadeh N, Piguion J, Sutherland D, and Nieman LK. Effect of single mid-follicular dose of the CDB 2914, a new anti-progestin, on folliculogenesis. Abstract 0-105, Proceedings of the 54th Annual Meeting of the American Society of Reproductive Medicine. San Francisco, California, October 4-9, 1998.
  • Hartog B, Gindoff P. Opiod Peptides and Reproduction. The Endocrinologist, 8:1, 1998.
  • Dubey AK, Cruz J, Hartog B and Gindoff PR. Serum collected on the day of embryo transfer from patients undergoing IVF shows toxic effect on development of mouse blastocyst. Abstract P-095, Proceedings of the 11th World Congress on IVF and Human Reproductive Genetics. Sydney, Australia, May, 1999.
  • Dubey AK, Cruz J, Hartog B and Gindoff PR. Integrin adhesions molecules expression during development of preimplantation human embryos. 55th Annual Meeting of ASRM, September 25-29th, Toronto, Canada, 1999.
  • Dubey AK, Nater, C, Sutherland, ML, Peak, D Hartog B, and Gindoff, PR. Apotosis in human: Expression of p53 in human preimplantation embryo. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Department of Pharmacology; George Washington University Medical Center, Washington, DC USA, IVF World Congress 2001.
  • Stratton P, Hartog B, Hajizadeh JP, Sutherland D, Merino M, Lee JY, and Nieman LK. A single mid-Follicular dose of CDB – 2914, a new antiprogestin inhibits colliculogenesis and endometrial differentiation in normally cycling women. Human Reproduction. 15: 1092-1099.
  • Dubey A, Cruz J, Hartog B, Gindoff PR. Expression of the αV Integrin Adhesion Molecule during Development of Preimplantation Human Embryos. Fertility and Sterility. 76, July 2001.
  • Stratton P. Levens ED, Hartog B, Piquion J, Wei Q, Merino M, Nieman LK, Endometrial effects of a single early luteal dose of selective progesterone receptor modulator CDB-2914. Fertility and Sterility. Feb 2009